TABLE OF CONTENTS I
LIST OF FIGURES X
LIST OF CHARTS XIX
EXECUTIVE SUMMARY 1

AUSTRALIA UROLOGICAL DEVICE MARKET OVERVIEW 1
COMPETITIVE ANALYSIS 3
MARKET TRENDS 6
MARKET DEVELOPMENTS 7
PROCEDURE NUMBERS 8
MARKETS INCLUDED 9
VERSION HISTORY 10
RESEARCH METHODOLOGY 11

Step 1: Project Initiation & Team Selection 11
Step 2: Prepare Data Systems and Perform Secondary Research 14
Step 3: Preparation for Interviews & Questionnaire Design 16
Step 4: Performing Primary Research 17
Step 5: Research Analysis: Establishing Baseline Estimates 19
Step 6: Market Forecast and Analysis 20
Step 7: Identify Strategic Opportunities 22
Step 8: Final Review and Market Release 23
Step 9: Customer Feedback and Market Monitoring 24
DISEASE OVERVIEW 25

2.1 BASIC ANATOMY 25
2.1.1 Urinary System 25
2.1.1.1 Male Urinary System 26
2.1.1.2 Female Urinary System 27
2.2 DISEASE TREATMENT AND DIAGNOSTICS 28
2.2.1 Benign Prostatic Hyperplasia 28
2.2.2 Urinary Incontinence 29
2.2.3 Urinary Tract Infections 31
2.2.4 Kidney Stones 32
2.2.5 Bladder Prolapse 34
2.2.6 Overactive Bladder 35
2.2.7 Prostatitis 36
2.2.8 Erectile Dysfunction 38
2.2.9 Cancer 39
2.2.9.1 Prostate Cancer 39
2.2.9.2 Bladder Cancer 40
2.2.10 Indications for Pelvic Organ Prolapse Repair 41
2.3 PATIENT DEMOGRAPHICS 42
PRODUCT ASSESSMENT 44

3.1 INTRODUCTION 44
3.2 PRODUCT PORTFOLIOS 44
3.2.1 Urinary Incontinence 44
3.2.1.1 Urinary Catheters 44
3.2.1.1.1 Intermittent Catheters 44
3.2.1.1.2 Foley Catheters 45
3.2.1.1.3 Male External Catheters 46
3.2.1.2 Urethral Bulking Agents 47
3.2.1.3 Incontinence Management Devices 48
3.2.1.3.1 Female Incontinence Slings 48
3.2.1.3.2 Male Implantable Devices 49
3.2.1.4 Urine Bags 51
3.2.1.4.1 Leg Bags 51
3.2.1.4.2 Night Bags 51
3.2.2 Pelvic Organ Prolapse Repair 56
3.2.2.1 Autologous Tissue as an Alternative to Vaginal Mesh 57
3.2.2.2 Product Matrix for Pelvic Organ Prolapse Repair 58
3.2.3 Stone Management 59
3.2.3.1 ESWL Equipment 59
3.2.3.2 ISWL Equipment 60
3.2.3.3 Holmium Lasers 60
3.2.3.4 Stone Fragment Retrieval Devices 61
3.2.3.5 Ureteral Stents 61
3.2.4 BPH Treatment 65
3.2.4.1 TURP 65
3.2.4.2 TUMT 66
3.2.4.3 TUNA 66
3.2.4.4 Prostatic Stents 67
3.2.4.5 Laser BPH 68
3.2.4.5.1 Photoselective Vaporization of the Prostate (PVP) 69
3.2.4.5.2 Laser Vaporization of the Prostate 70
3.2.4.5.3 Laser Ablation of the Prostate 71
3.2.4.5.4 Laser Resection of the Prostate 71
3.2.4.5.5 Laser Enucleation of the Prostate 72
3.2.5 Erectile Dysfunction 74
3.2.5.1 Penile Implants 74
3.2.5.1.1 Inflatable 74
3.2.5.1.2 Malleable 75
3.2.5.2 Vacuum 75
3.3 REGULATORY ISSUES AND RECALLS 77
3.3.1 Boston Scientific 77
3.3.1.1 Stone Management 77
3.3.1.2 Nephrostomy 79
3.3.2 C. R. Bard (Becton Dickinson) 80
3.3.2.1 Urinary Incontinence 80
3.3.2.2 Stone Management 85
3.3.2.3 Urological Endoscopes 85
3.3.2.4 Prostate Cancer Treatment 85
3.3.2.5 Nephrostomy 86
3.3.3 Coloplast 88
3.3.3.1 Urinary Catheter 88
3.3.3.2 Erectile Dysfunction 88
3.3.4 Cook Medical 89
3.3.4.1 Stone Management 89
3.3.4.2 Nephrostomy 90
3.3.5 Elekta 92
3.3.5.1 Prostate Cancer Treatment 92
3.3.6 Karl Storz 93
3.3.6.1 Urological Endoscopes 93
3.3.7 Olympus 94
3.3.7.1 Urological Endoscopes 94
3.4 CLINICAL TRIALS 96
3.4.1 Boston Scientific 96
3.4.1.1 Urinary Incontinence 96
3.4.1.2 BPH Treatment 97
3.4.1.3 Urological endoscopes 98
3.4.1.4 Nephrostomy 99
3.4.1.5 Erectile Dysfunction 100
3.4.2 C. R. Bard (Becton Dickinson) 101
3.4.2.1 Urinary Incontinence 101
3.4.2.2 Prostate Cancer Treatment 103
3.4.3 Coloplast 104
3.4.3.1 Urinary Incontinence 104
3.4.4 Cook Medical 107
3.4.4.1 Nephrostomy 107
3.4.5 Elekta 109
3.4.5.1 Prostate Cancer Treatment 109
3.4.6 Ethicon 111
3.4.6.1 Urinary Incontinence 111
3.4.7 Karl Storz 113
3.4.7.1 Stone Management 113
3.4.7.2 Urological Endoscopes 115
3.4.8 Laborie 118
3.4.8.1 Urodynamics 118
3.4.9 Medline 120
3.4.9.1 Urinary Incontinence 120
3.4.10 Olympus 121
3.4.10.1 Stone Management 121
3.4.10.2 BPH Treatment 122
3.4.10.3 Urological Endoscopes 123
AUSTRALIA UROLOGICAL DEVICE MARKET OVERVIEW 125

4.1 INTRODUCTION 125
4.2 CURRENCY EXCHANGE RATE 126
4.3 MARKET OVERVIEW 127
4.4 TREND ANALYSIS BY SEGMENT 133
4.5 DRIVERS AND LIMITERS 136
4.5.1 Market Drivers 136
4.5.2 Market Limiters 137
4.6 COMPETITIVE MARKET SHARE ANALYSIS 140
4.7 MERGERS AND ACQUISITIONS 147
4.8 COMPANY PROFILES 149
4.8.1 Boston Scientific 149
4.8.2 C. R. Bard (Becton Dickinson) 151
4.8.3 Coloplast 153
4.8.4 Cook Medical 154
4.8.5 Ethicon 155
4.8.6 Karl Storz 156
4.8.7 Laborie 157
4.8.8 Olympus 158
4.9 SWOT ANALYSIS 160
4.9.1 Boston Scientific 161
4.9.2 C. R. Bard (Becton Dickinson) 163
4.9.3 Coloplast 165
4.9.4 Cook Medical 166
4.9.5 Ethicon 168
4.9.6 Karl Storz 169
4.9.7 Laborie 170
4.9.8 Olympus 171
PROCEDURE NUMBERS 173

5.1 PROCEDURE OVERVIEW 173
5.2 URINARY INCONTINENCE PROCEDURES 180
5.2.1 Male Incontinence Management Procedures 182
5.2.2 Female Incontinence Management Procedures 185
5.3 PELVIC ORGAN PROLAPSE REPAIR 188
5.4 STONE MANAGEMENT PROCEDURES 190
5.4.1 ESWL Procedures 192
5.4.2 Transurethral Procedures 194
5.4.3 Ureteral Stent Placement Procedures 196
5.4.4 PCNL Procedures 198
5.5 BPH PROCEDURES 200
5.5.1 BPH Procedures 201
5.5.2 Prostatectomy Procedures 203
5.6 ERECTILE DYSFUNCTION MANAGEMENT PROCEDURES 205
URINARY INCONTINENCE DEVICE MARKET 208

6.1 INTRODUCTION 208
6.2 MARKET OVERVIEW 209
6.3 MARKET ANALYSIS AND FORECAST 214
6.3.1 Total Urinary Catheter Market 214
6.3.1.1 Intermittent Catheter Market 217
6.3.1.2 Foley Catheter Market 219
6.3.1.3 Male External Catheter Market 221
6.3.2 Total Urethral Bulking Agent Market 223
6.3.2.1 Male Urethral Bulking Agent Market 227
6.3.2.2 Female Urethral Bulking Agent Market 229
6.3.3 Total Incontinence Management Device Market 231
6.3.3.1 Total Female Incontinence Sling Market 234
6.3.3.1.1 Transvaginal Tape Female Incontinence Sling Market 240
6.3.3.1.2 Transobturator Female Incontinence Sling Market 242
6.3.3.1.3 Single-Incision Female Incontinence Sling Market 244
6.3.3.2 Total Male Implantable Incontinence Device Market 246
6.3.3.2.1 Male Incontinence Sling Market 251
6.3.3.2.2 Male Artificial Urinary Sphincter Market 253
6.4 DRIVERS AND LIMITERS 255
6.4.1 Market Drivers 255
6.4.2 Market Limiters 255
6.5 COMPETITIVE MARKET SHARE ANALYSIS 258
PELVIC ORGAN PROLAPSE REPAIR DEVICE MARKET 264

7.1 INTRODUCTION 264
7.2 MARKET OVERVIEW 268
7.3 MARKET ANALYSIS AND FORECAST 273
7.3.1 Total Pelvic Organ Prolapse Repair Device Market 273
7.3.2 Transvaginal Mesh Market 276
7.3.3 Sacrocolpopexy Mesh Market 279
7.4 DRIVERS AND LIMITERS 281
7.4.1 Market Drivers 281
7.4.2 Market Limiters 281
7.5 COMPETITIVE MARKET SHARE ANALYSIS 283
STONE MANAGEMENT DEVICE MARKET 287

8.1 INTRODUCTION 287
8.2 MARKET OVERVIEW 290
8.3 MARKET ANALYSIS AND FORECAST 296
8.3.1 ESWL Equipment Market 296
8.3.2 ISWL Equipment Market 299
8.3.3 Total Holmium Laser Market 301
8.3.3.1 Holmium Laser Equipment Market 304
8.3.3.2 Holmium Laser Fiber Market 306
8.3.4 Total Stone Fragment Retrieval Device Market 309
8.3.4.1 Nitinol Stone Fragment Retrieval Device Market 314
8.3.4.2 Stainless Steel Stone Fragment Retrieval Device Market 316
8.3.5 Ureteral Stent Market 318
8.3.6 Ureteral Guidewire Market 320
8.4 DRIVERS AND LIMITERS 322
8.4.1 Market Drivers 322
8.4.2 Market Limiters 323
8.5 COMPETITIVE MARKET SHARE ANALYSIS 325
BPH TREATMENT DEVICE MARKET 331

9.1 INTRODUCTION 331
9.1.1 Treatments 331
9.1.2 Comparison of TURP and Laser BPH Procedures 333
9.1.3 Emerging Technologies 333
9.2 MARKET OVERVIEW 335
9.3 MARKET ANALYSIS AND FORECAST 340
9.3.1 Total TURP Market 340
9.3.1.1 Monopolar Electrode Market 343
9.3.1.2 Bipolar Electrode Market 345
9.3.2 Total Laser BPH Market 347
9.3.2.1 Laser BPH Equipment Market 350
9.3.2.2 Laser BPH Fiber Market 352
9.3.3 UroLift® Market 354
9.3.4 Rezūm® Market 356
9.4 DRIVERS AND LIMITERS 358
9.4.1 Market Limiters 359
9.5 COMPETITIVE MARKET SHARE ANALYSIS 362
ERECTILE DYSFUNCTION DEVICE MARKET 366

10.1 INTRODUCTION 366
10.1.1 Low Testosterone Pharmaceutical Delivery 367
10.2 MARKET OVERVIEW 368
10.3 MARKET ANALYSIS AND FORECAST 373
10.3.1 Inflatable Erectile Dysfunction Device Market 373
10.3.2 Malleable Erectile Dysfunction Device Market 376
10.3.3 Vacuum Erection Device Market 378
10.4 DRIVERS AND LIMITERS 380
10.4.1 Market Drivers 380
10.4.2 Market Limiters 380
10.5 COMPETITIVE MARKET SHARE ANALYSIS 382
ABBREVIATIONS 386

Figure 1 1: Urological Device Market Share Ranking by Segment, Australia, 2019 4
Figure 1 2: Companies Researched in this Report, Australia 5
Figure 1 3: Factors Impacting the Urological Device Market by Segment, Australia 6
Figure 1 4: Recent Events in the Urological Device Market, 2017 – 2019 7
Figure 1 5: Urological Procedures Covered, Australia 8
Figure 1 6: Urological Device Markets Covered, Australia (1 of 2) 9
Figure 1 7: Urological Device Markets Covered, Australia (2 of 2) 10
Figure 1 8: Version History 10
Figure 3 1: Urinary Incontinence Treatments by Company (1 of 3) 53
Figure 3 2: Urinary Incontinence Treatments by Company (2 of 3) 54
Figure 3 3: Urinary Incontinence Treatments by Company (3 of 3) 55
Figure 3 4: Stone Management Devices by Company (1 of 3) 62
Figure 3 5: Stone Management Devices by Company (2 of 3) 63
Figure 3 6: Stone Management Devices by Company (3 of 3) 64
Figure 3 7: BPH Treatments by Company 73
Figure 3 8: Erectile Dysfunction Devices by Company 76
Figure 3 9: Class 2 Device Recall Auriga Laser System 77
Figure 3 10: Class 2 Device Recall Fiber Strippers and Cleavers 78
Figure 3 11: Class 2 Device Recall StarMedTec LightTrail Reusable Fibers 79
Figure 3 12: Class 2 Device Recall Malecot Catheter Set 79
Figure 3 13: Class 2 Device Recall Encore(TM) 26 Inflation Device 79
Figure 3 14: Class 2 Device Recall Bardex Lubricath 3Way 75cc Continuous Irrigation Foley Catheter 80
Figure 3 15: Class 2 Device Recall Intermittent Catheters 80
Figure 3 16: Class 2 Device Recall leg bag 80
Figure 3 17: Class 2 Device Recall SURESTEP 81
Figure 3 18: Class 2 Device Recall PureWick External Catheter 81
Figure 3 19: Class 2 Device Recall SURESTEP Tray, BARDEX I.C. COMPLETE CARE, Urine Meter, Temperature STATLOCK Stabilization Device 81
Figure 3 20: Class 2 Device Recall BARD Irrigation Syringe, Rx Only, Sterile 82
Figure 3 21: Class 2 Device Recall Magic3 82
Figure 3 22: Class 2 Device Recall Optionvm Urinary Catheter. Male use only. Latex Free. Sterile, Rx only. 82
Figure 3 23: Class 3 Device Recall SureStep Tray, with AddaFoley 83
Figure 3 24: Class 2 Device Recall BARDEX 83
Figure 3 25: Class 3 Device Recall BARD Toomey Irrigation Syringe 70cc 83
Figure 3 26: Class 3 Device Recall Antibacterial Hydro Personal Catheter 83
Figure 3 27: Class 2 Device Recall Magic3 Intermittent Catheter with Sure Grip Hydrophilic Coated Silicone Coude tip 84
Figure 3 28: Class 2 Device Recall Magic3 Hydrophiliccoated Female Intermittent Catheter 84
Figure 3 29: Class 2 Device Recall Bard 100 LatexFree Urinary Drainage Bag with AntiReflux Chamber and Bard EXLok Sampling 84
Figure 3 30: Class 2 Device Recall Bard Dimension Stone Basket 85
Figure 3 31: Class 2 Device Recall CMax 85
Figure 3 32: Class 2 Device Recall Bard BrachySource Seed Implants 85
Figure 3 33: Class 2 Device Recall I125 CE Marked QuickLink Cartridges 86
Figure 3 34: Class 2 Device Recall Bard 86
Figure 3 35: Class 2 Device Recall XForce Nephrostomy Balloon Dilation Catheter Kit with Inflation Device 87
Figure 3 36: Class 2 Device Recall SelfCath Pediatric Catheter 88
Figure 3 37: Class 2 Device Recall Coloplast Conveen Urine Collection Leg Bag 88
Figure 3 38: Class 2 Device Recall Genesis Malleable Penile Prosthesis 88
Figure 3 39: Class 2 Device Recall StoneBreaker 89
Figure 3 40: Class 2 Device Recall OptiLite MultiUse Holmium Laser Fibers 89
Figure 3 41: Class 2 Device Recall Cook MultiUse Holmium Laser Fibers 90
Figure 3 42: Class 2 Device Recall Cook Bush 90
Figure 3 43: Class 2 Device Recall Aprima" Access Nonvascular Introducer Set 90
Figure 3 44: Class 2 Device Recall Ascend AQ 91
Figure 3 45: Class 2 Device Recall Oncentra Brachy 4.5 92
Figure 3 46: Class 2 Device Recall Oncentra External Beam Treatment Planning Software 92
Figure 3 47: Class 2 Device Recall Oncentra External Beam Treatment Planning Software 92
Figure 3 48: Class 2 Device Recall Oncentra Brachy treatment planning system 92
Figure 3 49: Class 2 Device Recall STORZ High Flow Insufflation Tubing (with filter) 93
Figure 3 50: Class 2 Device Recall Image1 SPIES XLINK Camera Control Unit (CCU) 93
Figure 3 51: Class 2 Device Recall Ureteroreno Videoscope & Fiberscope 94
Figure 3 52: Class 2 Device Recall A20975A: Working insert, with ramp, one way; A20976A: Bridge, one way; A20977A; Bridge, two way 94
Figure 3 53: Class 2 Device Recall Olympus High Frequency Resection Electrodes 94
Figure 3 54: Class 2 Device Recall Ureteroreno videoscope URFV2 and URFV2R 95
Figure 3 55: Class 2 Device Recall HF Cable WA00014A 95
Figure 3 56: Post Market Study Of Single Incision Sling Versus Transobturator Sling for Stress Urinary Incontinence (Solyx) 96
Figure 3 57: Mid-Urethral Sling Tensioning Trial (MUST) 96
Figure 3 58: Prospective Registry for Patients Undergoing Surgery for Male Stress Urinary Incontinence 97
Figure 3 59: Stop or Ongoing Oral Anticoagulation in Patients Undergoing Pvp (SOAP) (SOAP) 97
Figure 3 60: LithoVue Single Use Disposable Ureteroscope 98
Figure 3 61: Comparing Treatment of Urolithiasis Between Disposable and Reusable Ureteroscope 98
Figure 3 62: Indwelling Stent Discoloration Project 99
Figure 3 63: Reduction of Stent Associated Morbidity by Minimizing Stent Material. 99
Figure 3 64: PROPPER Prospective Registry of Outcomes With Penile Prosthesis (PROPPER) 100
Figure 3 65: Patient Satisfaction During Outpatient Versus Inpatient Foley Catheter Induction of Labor 101
Figure 3 66: Foley Catheter vs a Self-contained Valved Urinary Catheter 101
Figure 3 67: Bladder Morphology Using 2 Different Catheter Designs 102
Figure 3 68: Outpatient Labor Induction With the Transcervical Foley Balloon 102
Figure 3 69: Medical and Economic Evaluation for Intermediate-risk Prostate Cancer (GETUGP05) 103
Figure 3 70: Detection of Clinically Significant Prostate Cancer Using Transperineal Targeted Biopsy Compared to Standard Transrectal Biopsy 103
Figure 3 71: Product Evaluation of a Newly Developed Intermittent Catheter. 104
Figure 3 72: Clinical Study Investigating Safety and Performance of a New Urinary Intermittent Catheter in Healthy Volunteers 104
Figure 3 73: Clinical Study Investigating Safety and Performance of a New Urinary Intermittent Catheters in Healthy Volunteers 104
Figure 3 74: Virtue® European Study 105
Figure 3 75: Exploratory Study Investigating Urodynamic Parameters During Catheterisation 105
Figure 3 76: Altis® 522 Trial - Treatment of Female Stress Urinary Incontinence 105
Figure 3 77: The European Study of Altis Single Incision Sling System for Female Stress Urinary Incontinence (EASY) 106
Figure 3 78: Do Hydrophilic Catheters Decrease Pain and Discomfort of a Patient During Urodynamic Study (HYDRUDS) 106
Figure 3 79: Efficacy Study of Antimicrobial Catheters to Avoid Urinary Infections in Spinal Cord Injured Patients (ESCALE) 106
Figure 3 80: Ureteral Stent Study 107
Figure 3 81: Impact Ureteral Sheath Design During Ureteroscopy 107
Figure 3 82: Optimization of Ureterolysis During Hysterectomy 108
Figure 3 83: Suctioning Flexible Ureteroscopy With Intelligent Control of Renal Pelvic Pressure 108
Figure 3 84: Evaluation Of Transperineal Ultrasound For Image Guidance In The Treatment Of Prostate Cancer in Men Following Prostatectomy 109
Figure 3 85: Use of Non-invasive 4D Ultrasound Clarity System in Prostate IMRT/RapidArc Therapy 109
Figure 3 86: Single Fraction Real-time High-Dose-Rate Brachytherapy in Patients With Low and Intermediate Risk Prostate Cancer (SINFRA_PROST) 110
Figure 3 87: Dose Escalation to Dominant Intraprostatic Lesions (DIL) With MRI-TRUS Fusion High Dose Rate (HDR) Prostate Brachytherapy (BRAPROST) 110
Figure 3 88: Combined Treatment for Mixed Incontinence (ESTEEM) 111
Figure 3 89: TVT-ABBREVO Versus SERASIS for the Treatment of Female Urinary Stress Incontinence: 1 Year Outcomes of a Comparative Study With 2 Trans-obturator Sub Mid Urethral Slings 111
Figure 3 90: Trans-obturator Mid-urethral Sling and the Single-incision Sling in Women With Stress Urinary Incontinence 112
Figure 3 91: Low-energy Extracorporeal Shockwave Treatment for Patients After Radical Prostatectomy 113
Figure 3 92: Low-Intensity Extracorporeal Shockwave Therapy and Vacuum Erectile Device as a Treatment for Peyronies Disease 113
Figure 3 93: Safety and Effect of Low-Energy Extracorporeal Shockwave Therapy (ESWT) on the Renal Allograft in Transplant Recipients. 114
Figure 3 94: Low Energy Shockwave Therapy (LE-SWT): A Novel Treatment for Chronic Kidney Disease 114
Figure 3 95: Narrow Versus Wide Focal Zones for Shock Wave Lithotripsy of Renal Calculi 114
Figure 3 96: Are the Stone Density and Location Useful Parameters for Small Kidney Stones? 115
Figure 3 97: Durability of Flexible Ureteroscopes and Causes of Infection During Flexible Ureterorenoscopy 115
Figure 3 98: Comparison of Different Energy Sources During TUR-P 115
Figure 3 99: Effects of Flexible Ureteroscopy on Renal Blood Flow 116
Figure 3 100: A Study of Blue Light Flexible Cystoscopy With Cysview in the Detection of Bladder Cancer in the Surveillance Setting 116
Figure 3 101: Blue Light Cystoscopy With Cysview® Registry (BLCCR) 116
Figure 3 102: Safety Study of Bipolar Versus Monopolar Transurethral Resection of Bladder Tumors 117
Figure 3 103: Multi-Center Comparison of Dual Lumen Versus Single Lumen Ureteroscopes 117
Figure 3 104: T-DOC® 5 Fr Pediatric Clinical Investigation 118
Figure 3 105: Air vs Water Catheters (AvW (Bonn)) 118
Figure 3 106: A Human Factor Study To Asses The Usability And Feasibility Of The Peritron+ During Intended Use 119
Figure 3 107: Portable Pves Study 119
Figure 3 108: Ambulatory Pessary Trial 119
Figure 3 109: Study to Compare CAUTI Rates Following ERASE CAUTI Tray Non-Silver vs Silver Coated Foley Catheters 120
Figure 3 110: Study to Compare CAUTI Rates Following ERASE CAUTI Tray Silver vs Silver Coated Foley Catheters 120
Figure 3 111: Trial Comparing Three Different Devices for Kidney Stone Removal During Percutaneous Surgery 121
Figure 3 112: Quality of Life in Kidney Stone Patients Undergoing Surgery 121
Figure 3 113: Prostate Vaporization Techniques in Canadian Hospital 122
Figure 3 114: Treatment of Symptomatic BPH Patients Undergoing Anticoagulant Therapy Using the PlasmaButton Vaporization Electrode 122
Figure 3 115: Assessment of Infection Control, Practice Efficiency, and Health Economics of Sheathed Versus Standard Cystoscopy 123
Figure 3 116: Results of Safety Guidewire Use in Ureteroscopic Stone Surgery 123
Figure 3 117: Transurethral En Bloc Versus Standard Resection of Bladder Tumour 123
Figure 3 118: PlasmaKinetic (PK) Button Vaporization Electrode for Treatment of Bladder Tumors (PK Button) 124
Figure 4 1: Currency Exchange Rate, 2019 126
Figure 4 2: Urological Device Market by Segment, Australia, 2016 – 2026 (US$M) 128
Figure 4 3: Urological Device Market by Segment, Australia, 2016 – 2026 (AU$M) 129
Figure 4 4: Urological Device Market Growth by Segment, 2016 – 2026 134
Figure 4 5: Drivers and Limiters, Urological Device Market, Australia, 2019 139
Figure 4 6: Leading Competitors, Urological Device Market, Australia, 2019 145
Figure 4 7: SWOT Analysis, Boston Scientific, 2018 (1 of 2) 161
Figure 4 8: SWOT Analysis, Boston Scientific, 2018 (2 of 2) 162
Figure 4 9: SWOT Analysis, C. R. Bard (Becton Dickinson), 2018 (1 of 2) 163
Figure 4 10: SWOT Analysis, C. R. Bard (Becton Dickinson), 2018 (2 of 2) 164
Figure 4 11: SWOT Analysis, Coloplast, 2018 165
Figure 4 12: SWOT Analysis, Cook Medical, 2018 (1 of 2) 166
Figure 4 13: SWOT Analysis, Cook Medical, 2018 (2 of 2) 167
Figure 4 14: SWOT Analysis, Ethicon, 2018 168
Figure 4 15: SWOT Analysis, Karl Storz, 2018 169
Figure 4 16: SWOT Analysis, Laborie, 2018 170
Figure 4 17: SWOT Analysis, Olympus, 2018 (1 of 2) 171
Figure 4 18: SWOT Analysis, Olympus, 2018 (2 of 2) 172
Figure 5 1: Procedure Codes Investigated, Australia, 2019 (1 of 2) 174
Figure 5 2: Procedure Codes Investigated, Australia, 2019 (2 of 2) 175
Figure 5 3: Urological Procedures by Type, Australia, 2016 – 2026 176
Figure 5 4: Urinary Incontinence Procedures by Type, Australia, 2016 – 2026 180
Figure 5 5: Male Incontinence Management Procedures by Type, Australia, 2016 – 2026 183
Figure 5 6: Female Incontinence Management Procedures by Type, Australia, 2016 – 2026 186
Figure 5 7: Pelvic Organ Prolapse Repair Procedures by Type, Australia, 2016 – 2026 188
Figure 5 8: Stone Management Procedures by Type, Australia, 2016 – 2026 190
Figure 5 9: ESWL Procedures, Australia, 2016 – 2026 192
Figure 5 10: Transurethral Procedures by Type, Australia, 2016 – 2026 194
Figure 5 11: Ureteral Stent Placement Procedures, Australia, 2016 – 2026 196
Figure 5 12: PCNL Procedures, Australia, 2016 – 2026 198
Figure 5 13: BPH Procedures by Type, Australia, 2016 – 2026 201
Figure 5 14: Prostatectomy Procedures by Type, Australia, 2016 – 2026 203
Figure 5 15: Erectile Dysfunction Management Procedures by Type, Australia, 2016 – 2026 206
Figure 6 1: Urinary Incontinence Device Market by Segment, Australia, 2016 – 2026 (US$M) 210
Figure 6 2: Urinary Incontinence Device Market by Segment, Australia, 2016 – 2026 (AU$M) 210
Figure 6 3: Urinary Catheter Market by Segment, Australia, 2016 – 2026 (US$M) 215
Figure 6 4: Urinary Catheter Market by Segment, Australia, 2016 – 2026 (AU$M) 215
Figure 6 5: Intermittent Catheter Market, Australia, 2016 – 2026 217
Figure 6 6: Foley Catheter Market, Australia, 2016 – 2026 219
Figure 6 7: Male External Catheter Market, Australia, 2016 – 2026 221
Figure 6 8: Urethral Bulking Agent Market by Segment, Australia, 2016 – 2026 (US$M) 223
Figure 6 9: Urethral Bulking Agent Market by Segment, Australia, 2016 – 2026 (AU$M) 224
Figure 6 10: Total Urethral Bulking Agent Market, Australia, 2016 – 2026 225
Figure 6 11: Male Urethral Bulking Agent Market, Australia, 2016 – 2026 227
Figure 6 12: Female Urethral Bulking Agent Market, Australia, 2016 – 2026 229
Figure 6 13: Incontinence Management Device Market by Segment, Australia, 2016 – 2026 (US$M) 232
Figure 6 14: Incontinence Management Device Market by Segment, Australia, 2016 – 2026 (AU$M) 232
Figure 6 15: Female Incontinence Sling Market by Type, Australia, 2016 – 2026 (US$M) 235
Figure 6 16: Female Incontinence Sling Market by Type, Australia, 2016 – 2026 (AU$M) 236
Figure 6 17: Total Female Incontinence Sling Market, Australia, 2016 – 2026 238
Figure 6 18: Transvaginal Tape Female Incontinence Sling Market, Australia, 2016 – 2026 240
Figure 6 19: Transobturator Female Incontinence Sling Market, Australia, 2016 – 2026 242
Figure 6 20: Single-Incision Female Incontinence Sling Market, Australia, 2016 – 2026 244
Figure 6 21: Male Implantable Incontinence Device Market by Segment, U.S., 2016 – 2026 (US$M) 247
Figure 6 22: Male Implantable Incontinence Device Market by Segment, U.S., 2016 – 2026 (AU$M) 247
Figure 6 23: Total Male Implantable Incontinence Device Market, Australia, 2016 – 2026 249
Figure 6 24: Male Incontinence Sling Market, Australia, 2016 – 2026 251
Figure 6 25: Male Artificial Urinary Sphincter Market, Australia, 2016 – 2026 253
Figure 6 26: Drivers and Limiters, Urinary Incontinence Device Market, U.S., 2018 257
Figure 6 27: Leading Competitors, Urinary Incontinence Device Market, Australia, 2018 262
Figure 7 1: Devices Included in the Australian Register of Therapeutic Good Administration, Effective January 2018 (1 of 2) 266
Figure 7 2: Devices Included in the Australian Register of Therapeutic Good Administration, Effective January 2018 (2 of 2) 267
Figure 7 3: Pelvic Organ Prolapse Repair Device Market by Segment, Australia, 2016 – 2026 (US$M) 270
Figure 7 4: Pelvic Organ Prolapse Repair Device Market by Segment, Australia, 2016 – 2026 (AU$M) 270
Figure 7 5: Total Pelvic Organ Prolapse Repair Device Market, Australia, 2016 – 2026 274
Figure 7 6: Transvaginal Mesh Market, Australia, 2016 – 2026 277
Figure 7 7: Sacrocolpopexy Mesh Market, Australia, 2016 – 2026 279
Figure 7 8: Drivers and Limiters, Pelvic Organ Prolapse Repair Device Market, Australia, 2019 282
Figure 7 9: Leading Competitors, Pelvic Organ Prolapse Repair Market, Australia, 2019 285
Figure 8 1: Stone Management Device Market by Segment, Australia, 2016 – 2026 (US$M) 291
Figure 8 2: Stone Management Device Market by Segment, Australia, 2016 – 2026 (AU$M) 292
Figure 8 3: ESWL Equipment Market, Australia, 2016 – 2026 297
Figure 8 4: ISWL Equipment Market, U.S., 2016 – 2026 299
Figure 8 5: Holmium Laser Market by Segment, Australia, 2016 – 2026 (US$M) 301
Figure 8 6: Holmium Laser Market by Segment, Australia, 2016 – 2026 (AU$M) 302
Figure 8 7: Holmium Laser Equipment Market, Australia, 2016 – 2026 304
Figure 8 8: Holmium Laser Fiber Market, Australia, 2016 – 2026 307
Figure 8 9: Stone Fragment Retrieval Device Market by Segment, Australia, 2016 – 2026 (US$M) 309
Figure 8 10: Stone Fragment Retrieval Device Market by Segment, Australia, 2016 – 2026 (AU$M) 310
Figure 8 11: Total Stone Fragment Retrieval Device Market, Australia, 2016 – 2026 312
Figure 8 12: Nitinol Stone Fragment Retrieval Device Market, Australia, 2016 – 2026 314
Figure 8 13: Stainless Steel Stone Fragment Retrieval Device Market, Australia, 2016 – 2026 316
Figure 8 14: Ureteral Stent Market, Australia, 2016 – 2026 318
Figure 8 15: Ureteral Guidewire Market, Australia, 2016 – 2026 320
Figure 8 16: Drivers and Limiters, Stone Management Device Market, Australia, 2019 324
Figure 8 17: Leading Competitors, Stone Management Device Market, Australia, 2019 329
Figure 9 1: BPH Treatment Device Market by Segment, U.S., 2016 – 2026 (US$M) 336
Figure 9 2: BPH Treatment Device Market by Segment, U.S., 2016 – 2026 (AUS$M) 336
Figure 9 3: TURP Market by Segment, Australia, 2016 – 2026 (US$M) 341
Figure 9 4: TURP Market by Segment, Australia, 2016 – 2026 (AUS$M) 341
Figure 9 5: Monopolar Electrode Market, Australia, 2016 – 2026 343
Figure 9 6: Bipolar Electrode Market, U.S., 2016 – 2026 345
Figure 9 7: Laser BPH Market by Segment, Australia, 2016 – 2026 (US$M) 348
Figure 9 8: Laser BPH Market by Segment, Australia, 2016 – 2026 (AUS$M) 348
Figure 9 9: Laser BPH Equipment Market, Australia, 2016 – 2026 350
Figure 9 10: Laser BPH Fiber Market, Australia, 2016 – 2026 352
Figure 9 11: UroLift Market, Australia, 2016 – 2026 354
Figure 9 12: Rezūm Market, Australia, 2016 – 2026 356
Figure 9 13: Drivers and Limiters, BPH Treatment Device Market, Australia, 2019 361
Figure 9 14: Leading Competitors, BPH Treatment Device Market, Australia, 2019 364
Figure 10 1: Erectile Dysfunction Device Market by Segment, Australia, 2016 – 2026 (US$M) 368
Figure 10 2: Erectile Dysfunction Device Market by Segment, Australia, 2016 – 2026 (AUS$M) 369
Figure 10 3: Inflatable Erectile Dysfunction Device Market, Australia, 2016 – 2026 374
Figure 10 4: Malleable Erectile Dysfunction Device Market, Australia, 2016 – 2026 376
Figure 10 5: Vacuum Erection Device Market, Australia, 2016 – 2026 378
Figure 10 6: Drivers and Limiters, Erectile Dysfunction Device Market, Australia, 2019 381
Figure 10 7: IIEF-5 Comparison for Penile Implant 383
Figure 10 8: Leading Competitors, Erectile Dysfunction Device Market, Australia, 2019 384

Applied Medical
BARD
Bonro Medical
Boston Scientific
Coloplast
Contura
ConvaTek
Cook Medical
Dornier MedTech
EDAP TMS
EMS
Endo Personal Care
Endotherapeutics
Getz Healthcare
High Tech Medical
Hollister
Johnson & Johnson
Karl Storz
KESSEL Medintim
Laborie
Lamidey Noury
Lumenis
Medtronic
Neogenix
Olympus
Richard Wolf
Siemens
Stryker
Surgical Implants
Teleflex
Zephyr Surgical Implants